Cargando…
Use of proton pump inhibitors is associated with a higher risk of pneumonia in cirrhotic patients: a systematic review and meta-analysis
BACKGROUND: Proton pump inhibitors (PPIs) are commonly prescribed for cirrhotic patients. However, the use of PPIs in these patients may increase the risk of bacterial infection. The current study aimed to investigate the risk of developing pneumonia among cirrhotic patients exposed to PPIs. METHODS...
Autores principales: | Wongtrakul, Wasit, Charoenngnam, Nipith, Ungprasert, Patompong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hellenic Society of Gastroenterology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196626/ https://www.ncbi.nlm.nih.gov/pubmed/32382231 http://dx.doi.org/10.20524/aog.2020.0483 |
Ejemplares similares
-
The correlation between heart failure and the risk of ischemic colitis: a systematic review and meta-analysis
por: Wongtrakul, Wasit, et al.
Publicado: (2021) -
Authors’ reply
por: Wongtrakul, Wasit, et al.
Publicado: (2020) -
Association between statin use & risk of diffuse large B-cell lymphoma: A systematic review & meta-analysis
por: Ponvilawan, Ben, et al.
Publicado: (2023) -
Meta-analysis associates proton pump inhibitor use with higher pneumonia risk in cirrhotic patients: mining for “diamonds” in the coal
por: Tziatzios, Georgios, et al.
Publicado: (2020) -
Effect of proton pump inhibitors on mortality of cirrhotic patients with pneumonia
por: Hung, Tsung-Hsing, et al.
Publicado: (2019)